P15-04. Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells

by Gilbert P, Wang M, Wood B, Gao H, Greene KM, Ozaki DA, Yu X, Todd CA, Montefiori DC, Sarzotti-Kelsoe M
Published 2009-10-01

P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials

by Stevens G, Rodriguez-Chavez IR, Needham L, Ozaki D, Hural J, Denny T, Cleland N, Cox J, Sarzotti-Kelsoe M, Stiles T, Tarragona-Fiol T, Simkins A
Published 2009-10-01

Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cells

by Sarzotti-Kelsoe M, Daniell X, Todd CA, Bilska M, LaBranche C, Perez LG, Ochsenbauer C, Kappes J, Rountree W, Ozaki DA, Kim JH, McLinden R, Denny T, Montefiori DC
Published 2012-09-01